2005
DOI: 10.1097/01.sla.0000150258.36236.e0
|View full text |Cite
|
Sign up to set email alerts
|

Treatment With Simvastatin Suppresses the Development of Experimental Abdominal Aortic Aneurysms in Normal and Hypercholesterolemic Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
56
0
3

Year Published

2006
2006
2017
2017

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 154 publications
(62 citation statements)
references
References 63 publications
3
56
0
3
Order By: Relevance
“…elastase-induced AAAs, but that aneurysm development is suppressed by treatment with statins in both normal and Apo-E (−/−) mice. 51 This finding likely reflects the pleiotropic effects of statins acting to interfere with key inflammatory signaling pathways as a mechanism of suppressing aneurysmal degeneration. Recent clinical studies have also highlighted the potential benefits of treatment with statins in patients with AAAs.…”
Section: Elastase-induced Aaas In Genetically Altered Micementioning
confidence: 99%
“…elastase-induced AAAs, but that aneurysm development is suppressed by treatment with statins in both normal and Apo-E (−/−) mice. 51 This finding likely reflects the pleiotropic effects of statins acting to interfere with key inflammatory signaling pathways as a mechanism of suppressing aneurysmal degeneration. Recent clinical studies have also highlighted the potential benefits of treatment with statins in patients with AAAs.…”
Section: Elastase-induced Aaas In Genetically Altered Micementioning
confidence: 99%
“…Statins can reduce MMP secretion in cultured macrophages 14 and aneurysmal explants 15 . They have also been shown recently to suppress aneurysm expansion in normal and hypercholesterolaemic animal models, suggesting that their anti-inflammatory effects are independent of their lipid-lowering activity 16,17 .…”
Section: Introductionmentioning
confidence: 99%
“…Statins have potent LDL lowering effects via inhibition of the rate-limiting step in cholesterol synthesis. There are a number of experimental models which demonstrate the potential for treating the vasculature with statins to inhibit matrix formation [24,25], cellular proliferation [6] and vascular aneurysm formation [82]. Although valve replacement is the current treatment of choice for severe critical aortic stenosis, future insights into the mechanisms of calcification and its progression may indicate a role for lipid lowering therapy in modifying the rate of progression of stenosis.…”
Section: Development Of Future Medical Therapies For Calcific Aortic mentioning
confidence: 99%